Human papillomavirus infectious entry and trafficking is a rapid process

Journal of Virology

Volumn 89, Issue 17, 2015, Pages 8727-8732

  Broniarczyk, Justyna ^a,b   Massimi, Paola ^a   Bergant, Martina ^c   Banks, Lawrence ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b ADAM MICKIEWICZ UNIVERSITY   (Poland)

^c UNIVERSITY OF NOVA GORICA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL MIGRATION; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CELL POPULATION; CONTROLLED STUDY; ENDOSOME; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MITOSIS; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; VIRION; VIRUS ENTRY; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS TRANSMISSION; ACTIVE TRANSPORT; CELL DIVISION; CELL LINE; GENETICS; HEK293 CELL LINE; KERATINOCYTE; METABOLISM; PHYSIOLOGY; REPORTER GENE; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

VIRUS DNA;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL DIVISION; CELL LINE; DNA, VIRAL; GENES, REPORTER; HEK293 CELLS; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATINOCYTES; MITOSIS; PAPILLOMAVIRUS INFECTIONS; VIRUS INTERNALIZATION;

EID: 84938926553     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00722-15     Document Type: Article

References (16)

1. Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, Stanley MA. 2012. The biology and life-cycle of human papillomaviruses. Vaccine Suppl 5:F55-F70.
2. Schelhaas M, Shah B, Holzer M, Blattmann P, Kühling L, Day PM, Schiller JT, Helenius A. 2012. Entry of human papillomavirus type 16 by actin-dependent, clathrin-and lipid raft-independent endocytosis. PLoS Pathog 8:e1002657. http://dx.doi.org/10.1371/journal.ppat.1002657.
3. Spoden G, Kühling L, Cordes N, Frenzel B, Sapp M, Boller K, Florin L, Schelhaas M. 2013. Human papillomavirus types 16, 18, and 31 share similar endocytic requirements for entry. J Virol 87:7765-7773. http://dx.doi.org/10.1128/JVI.00370-13.
4. Bergant M, Banks L. 2013. SNX17 facilitates infection with diverse papillomavirus types. J Virol 87:1270-1273. http://dx.doi.org/10.1128/JVI.01991-12.
5. Florin L, Becker KA, Lambert C, Nowak T, Sapp C, Strand D, Streeck RE, Sapp M. 2006. Identification of a dynein interacting domain in the papillomavirus minor capsid protein L2. J Virol 80:6691-6696. http://dx.doi.org/10.1128/JVI.00057-06.
6. Popa A, Zhang W, Harrison MS, Goodner K, Kazakov T, Goodwin EC, Lipovsky A, Burd CG, DiMaio D. 2015. Direct binding of retromer to human papillomavirus type 16 minor capsid protein L2 mediates endosome exit during viral infection. PLoS Pathog 11:e1004699. http://dx.doi.org/10.1371/journal.ppat.1004699.
7. Day PM, Thompson CD, Schowalter RM, Lowy DR, Schiller JT. 2013. Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection. J Virol 87:3862-3870. http://dx.doi.org/10.1128/JVI.03222-12.
8. Zhang W, Kazakov T, Popa A, DiMaio D. 2014. Vesicular trafficking of incoming human papillomavirus 16 to the Golgi apparatus and endoplasmic reticulum requires γ-secretase activity. mBio 5:e01777-14.
9. Aydin I, Weber S, Snijder B, Samperio Ventayol P, Kühbacher A, Becker M, Day PM, Schiller JT, Kann M, Pelkmans L, Helenius A, Schelhaas M. 2014. Large scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomaviruses. PLoS Pathog 10:e1004162. http://dx.doi.org/10.1371/journal.ppat.1004162.
10. Pyeon D, Pearce SM, Lank SM, Ahlquist P, Lambert PF. 2009. Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog 5:e1000318. http://dx.doi.org/10.1371/journal.ppat.1000318.
11. Day PM, Baker CC, Lowy DR, Schiller JT. 2004. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci U S A 101:14252-14257. http://dx.doi.org/10.1073/pnas.0404229101.
12. Huotari J, Helenius A. 2011. Endosome maturation. EMBO J 30:3481-3500. http://dx.doi.org/10.1038/emboj.2011.286.
13. Buck CB, Pastrana DV, Lowy DR, Schiller JT. 2005. Generation of HPV pseudovirions using transfection and their use in neutralization assays. Methods Mol Med 119:445-462.
14. Banks L, Barnett SC, Crook T. 1990. HPV-16 E7 functions at the G1 to S phase transition in the cell cycle. Oncogene 5:833-837.
15. Christensen ND, Dillner J, Eklund C, Carter JJ, Wipf GC, Reed CA, Cladel NM, Galloway DA. 1996. Surface conformational and linear epitopes on HPV-16 and HPV-18L1 virus-like particles as defined by monoclonal antibodies. Virology 223:174-184. http://dx.doi.org/10.1006/viro.1996.0466.
16. Bernardi R, Pandolfi PP. 2007. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 8:1006-1016. http://dx.doi.org/10.1038/nrm2277.